Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
09/2010
09/28/2010US7803945 Tetrahydropyridothiophenes
09/28/2010US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases
09/28/2010US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents
09/28/2010CA2415475C Pyrrolo[2,1-b][1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity
09/23/2010WO2010107816A2 Nucleic acid binding dyes and uses therefor
09/23/2010WO2010106016A1 Pyrimidine derivatives used as itk inhibitors
09/23/2010US20100240904 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3--2-thiophenecarboxamide
09/23/2010US20100240889 Urea Derivatives Methods For Their Manufacture And Uses Thereof
09/23/2010US20100240693 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
09/23/2010US20100236631 Thiazolothiazole derivatives and organic electronic device using the same
09/22/2010EP2229381A1 Gamma secretase modulators
09/22/2010EP1913004B1 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
09/22/2010CN101838278A Method for synthesizing cefaloglycin intermediate
09/21/2010US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
09/21/2010US7799801 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2010US7799800 Lipid-modified immune response modifiers
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799776 taurine-substituted naphthaquinone derivatives, used for treating vision defects, neurodegenerative disorders, psychological disorders, cancer and bacterialor viral infections
09/21/2010CA2477720C Quinoline derivatives
09/16/2010WO2010104106A1 Method for producing optically active diamine derivative
09/16/2010WO2010104078A1 Process for producing diamine derivative
09/16/2010WO2010103130A2 Novel bicyclic heterocycles
09/16/2010WO2010103115A1 Process for preparing brinzolamide
09/16/2010WO2010075204A3 Gamma secretase modulators
09/16/2010US20100234610 Method for producing optically active ester and method for producing optically active carboxylic acid
09/16/2010US20100234609 Fused ring spiroketal derivative and use thereof as anti-diabetic drug
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234345 Novel compounds as cannabinoid receptor ligands
09/16/2010US20100233710 Nucleic acid binding dyes and uses therefor
09/16/2010CA2754890A1 Novel bicyclic heterocycles
09/15/2010EP2227469A1 Mapk/erk kinase inhibitors
09/15/2010EP2079690B1 3-aza-bicyclo[3.1.0]hexane derivatives
09/15/2010EP2027132B1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
09/15/2010CN101835778A Hdac inhibitors
09/15/2010CN101835776A Fused imidazoles for cancer treatment
09/15/2010CN101835752A Heterocyclic amides useful for the treatment of cancer and psoriasis
09/14/2010US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia
09/14/2010US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents
09/14/2010US7795257 Organic compounds
09/14/2010US7795247 13-Cyclohexyl-5-(2-pyrrolidin-1-ylethoxy)-6,7-dihydro-5H-indolo[2.1-a][2]benzazepine-10-carboxylic acid, for example; use for the treatment or prevention of infection by hepatitis C virus
09/08/2010EP2225250A2 Bicyclic ppat inhibitors as antibacterial agents
09/08/2010EP2225216A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/08/2010EP2225215A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
09/08/2010EP2007770B1 Imidazo compounds
09/08/2010CN101824043A Compositions useful as inhibitors of protein kinases
09/07/2010US7790883 5-[[(2,3-difluorophenyl)methyl]thio]-7-[[(1R)-2-hydroxy-1-methylethyl]amino]-3-[2-(phenylsulfonyl)ethyl]thiazolo[4,5-d]pyrimidin-2-(3H)-one; protection of the thiazole nitrogen atom while reacting a 7- leaving group with an amine for an amination reaction to result in improved yields; efficiency
09/07/2010US7790750 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
09/07/2010US7790741 Imidazothiazoles and imidazoxazoles
09/07/2010US7790729 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), receptor antagonists, such as N-(3-Fluoro-4-(2- (thiophen-2-yl)thieno[3,2- b]pyridin-7- yloxy)phenylcarbamothio- yl)-2-phenylacetamide, used for treating angiogenesis-mediated cell proliferative diseases or as antitumor agents
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790710 Imidazopyridine derivatives useful as iNOS inhibitors
09/07/2010CA2465079C Substituted thiene-3-ylsulphonylamino(thio)carbonyltriazolin(ethi)ones
09/02/2010WO2010097798A1 6-phenyl-2-[((piperidin-4-ylmethyl)-piperazin-1yl) or piperazin 1-ylmethyl)-piperidin-1-yl)]-imidazo[2,1-b][1,3,4]thiadiazole derivatives and their use
09/02/2010US20100222343 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
09/02/2010US20100222321 Inhibitors of akt activtiy
09/01/2010EP2222682A1 Imidazo-thiazole derivatives as protein kinase inhibitors
09/01/2010EP2004657B1 Condensed imidazole derivatives as aldosterone synthase inhibitors
09/01/2010EP1560488B1 Antibacterial agents
09/01/2010CN101821256A Novel heterocyclic compounds as mGlu5 antagonists
09/01/2010CN101817836A Method for preparing imidazo[2,1-b]thiazole derivative by catalysis of copper salt
08/2010
08/31/2010US7786163 such as 6-Amino-5-oxo-hexahydro-pyrrolo[2,1-b]thiazole-3-carbonitrile hydrochloride, useful as Dipeptidyl peptidase-IV inhibitors, for the treatment of diabetes, hyperglycemia, Syndrome X, obesity, atherosclerosis, inflammatory bowel disease and as immunology modulators
08/26/2010WO2010096389A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
08/26/2010WO2010011964A3 Imaging agents useful for identifying ad pathology
08/26/2010US20100217000 Process for the Preparation of Thiazolopyrimidines
08/26/2010US20100216999 Process for preparation of pure polymorphic form 1 of clopidogrel hydrogensulfate
08/26/2010US20100216809 Piperidine/piperazine derivatives
08/26/2010US20100216789 Rho-kinase inhibitors
08/26/2010US20100216746 Chemical compounds
08/26/2010CA2752596A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
08/25/2010EP2221301A1 Heteroaryloxy quinazoline derivative
08/25/2010EP1737844B1 Bicyclic anthranilamide derivatives useful as insecticides
08/25/2010CN101812078A Heterocyclic dihydropyridine compound and synthesis method thereof
08/24/2010US7781476 Serotonin and melatonergic ligands such as 10-(4-Methylpiperazin-1-ylmethyl)-5-thia-4b-aza-indeno[2,1-a]indene-5,5-dioxide, used for the treatment of psychological disorders, side effect reduction of antipsychotic drugs, neurodegenerative disorders, chemotherapy-induced vomiting and eating disorders
08/24/2010US7781451 glucose kinase activators such as 3-Cyclopentyl-2-(4-ethoxymethanesulfonyl-phenyl)-N-(6-methoxy-thiazolo[5,4-b]pyridin-2-yl)-propionamide, enantiomorphs or mixtures, used for the treament of impaired glucose tolerance, non-insulin dependent diabetes and obesity in mammals
08/24/2010CA2524377C Thiadiazine derivatives and use thereof as positive ampa receptor modulators
08/19/2010WO2010092181A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/19/2010WO2010092111A2 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/19/2010WO2009061453A8 Solubilized thiazolopyridines
08/19/2010US20100210850 Process for the preparation of 6-substituted-imidazo [2,1-b] thiazole-5-sulfonyl halide
08/19/2010US20100210762 Heterocyclic compound, ultraviolet absorbent and composition containing the same
08/19/2010US20100210657 Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
08/19/2010CA2750913A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/18/2010EP2218723A2 Processes for the preparations of cefepime
08/18/2010EP2218464A1 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/18/2010EP2217606A1 Solubilized thiazolopyridines
08/18/2010EP2217588A1 Inhibitors of histone deacetylase
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/18/2010CN101805699A Method for preparing gliocladicillin C and application thereof
08/18/2010CN101805358A Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in treatment of type 2 diabetes
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776877 N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776791 N-heterocyclyl phenyl-substituted cyclic ketoenols
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/12/2010WO2010090716A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010WO2007019344A8 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
08/12/2010US20100204472 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 152